Versant Venture Management, LLC
CIK
1560009
Location
San Francisco, CA
Portfolio Value
Small
$140,968,881
Diversification
Moderately concentrated
Filing Date
Global Rank
#4,632
/ 8,232
▲ 118
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-42.5%
Period ended 2 months ago
Filed May 5, 2026 · 39d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-52.0%
SPY
+76.5%
Annualised alpha
-42.5%
Max drawdown
−82.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
37.1%
−8.6 pts
Top 5
94.1%
−4.9 pts
Top 10
100.0%
0.0 pts
HHI
2,338
Moderately concentrated−843
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $140,968,881 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | −1,201,907 | 3,180,780 | $52,323,831 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | 12,166,109 | $27,495,406 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
7 positions ·
$140,968,881 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 3,180,780 | $52,323,831 | 37.12% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 12,166,109 | $27,495,406 | 19.50% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Held | 2,656,888 | $24,310,525 | 17.25% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 1,525,820 | $21,437,771 | 15.21% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 542,628 | $7,086,721 | 5.03% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 148,831 | $7,079,890 | 5.02% | |
| SKYE |
Skye Bioscience, Inc.
Healthcare
|
Held | 2,007,704 | $1,234,737 | 0.88% |